Product overview
Vaccine type
Diphtheria-Tetanus (reduced antigen content)
Commercial Name
Tetadif
Manufacturer
BB- NCIPD EAD (Bul Bio-National Center of Infectious and Parasitic Diseases EAD)
Responsible NRA
Bulgarian Drug Agency
Country
Bulgaria
URL
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
10
Diluent
Not Applicable
Route of Administration
Intramuscular
Shelf Life
36 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 14
Secondary Packaging
Carton of 10 vials (100 doses) [Dimensions: 12.5 x 5.5 x 5.7 cm]
Tertiary Packaging
Box containing 192 cartons of 10 vials (19 200 doses / 1 920 vials) [Dimensions: 58 x 58 x 53 cm]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
thiomersal
Vaccine Preservative Concentration
0.01% w/v
Cold Chain Volume
3.91 cm3/dose (in secondary packaging)
Attachments
